PTCT - PTC Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$106.14
DETAILS
HIGH:
$130.00
LOW:
$85.00
MEDIAN:
$108.00
CONSENSUS:
$106.14
UPSIDE:
49.37%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,548,919 | $126.3M | 0.1% | -91,462 | DECREASED |
| Dalio | 0 | $0 | -- | -- | SOLD |
| Greenblatt | 0 | $0 | -- | -- | SOLD |
| Wood | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-19 | SCHMERTZLER MICHAEL | director | SELL | 5,335 | $72.86 | $389K |
| 2026-08-19 | SCHMERTZLER MICHAEL | director | SELL | 7,165 | $73.67 | $528K |
| 2026-08-20 | SCHMERTZLER MICHAEL | director | SELL | 9,419 | $70.78 | $667K |
| 2026-08-20 | SCHMERTZLER MICHAEL | director | SELL | 2,390 | $71.88 | $172K |
| 2026-08-20 | SCHMERTZLER MICHAEL | director | SELL | 691 | $72.92 | $50K |
| 2026-08-17 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | M-Exempt | 2,813 | $25.69 | $72K |
| 2026-08-17 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 1,844 | $72.39 | $133K |
| 2026-08-17 | Boulding Mark Elliott | officer: EXEC. VP AND CLO | SELL | 969 | $72.90 | $71K |
| 2026-08-04 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 10,292 | $68.57 | $706K |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | 14,000 | $51.96 | $727K |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | 17,875 | $38.10 | $681K |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | 11,250 | $39.42 | $443K |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | A-Award | 2,000 | -- | -- |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | A-Award | 4,000 | -- | -- |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | 33,250 | $66.49 | $2.2M |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | A-Award | 3,475 | $75.39 | $262K |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | A-Award | 1,738 | $75.39 | $131K |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | -- | -- | -- |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | 25,000 | $46.54 | $1.2M |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | director | ? | 27,500 | $76.74 | $2.1M |
| 2026-07-14 | Gravier Pierre | officer: CHIEF FINANCIAL OFFICER | SELL | 3,494 | $80.35 | $281K |
| 2026-07-09 | Smith Mary L. | director | M-Exempt | 10,000 | $42.95 | $430K |
| 2026-07-09 | Smith Mary L. | director | SELL | 5,834 | $90.00 | $525K |
| 2026-07-09 | Smith Mary L. | director | M-Exempt | 5,834 | $42.95 | $251K |
| 2026-07-09 | Almstead Neil Gregory | officer: CHIEF TECHNICAL OPS OFFICER | SELL | 2,464 | $90.25 | $222K |